Editorial: Osteosarcopenia: A Geriatric Giant of the XXI Century.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

1. Dual-targeted hybrid nanovesicles coordinated bone-muscle regeneration via regulating the DUSP4/p38 MAPK pathway to reverse osteosarcopenia.Journal of nanobiotechnology · 2026
   Article
2. Osteosarcopenia, bone-muscle interactions, and frailty risk: A prospective cohort study of community-dwelling older adults.Aging clinical and experimental research · 2025
   Article
3. Immunosenescence and the Geriatric Giants: Molecular Insights into Aging and Healthspan.Medical sciences (Basel, Switzerland) · 2025
   Review
4. Prediction of Fragility Fractures and Mortality in a Cohort of Geriatric Patients.Journal of cachexia, sarcopenia and muscle · 2024
   Article
5. Osteosarcopenia predicts greater risk of functional disability than sarcopenia: a longitudinal analysis of FraDySMex cohort study.The journal of nutrition, health & aging · 2024
   Article
6. Three-Year Mortality of Older Hospitalized Patients with Osteosarcopenia: Data from the OsteoSys Study.Nutrients · 2024
   Article
7. Undernutrition risk and obesity increase the risk of osteosarcopenia in Mexican adults aged 50 and over: a prospective cohort study.Frontiers in nutrition · 2024
   Article
8. Dietary Patterns and Healthy or Unhealthy Aging.Gerontology · 2024
   Review
9. Healthy Aging and Dietary Patterns.Nutrients · 2022
   Review
10. Prevalence of sarcopenia among Saudis and its association with lifestyle behaviors: Protocol for cross-sectional study.PloS one · 2022
    Article
11. Osteosarcopenia, an Asymmetrical Overlap of Two Connected Syndromes: Data from the OsteoSys Study.Nutrients · 2021
    Observational
12. A Pilot Study to Validate a Wearable Inertial Sensor for Gait Assessment in Older Adults with Falls.Sensors (Basel, Switzerland) · 2021
    Article
13. Letter tot the Editor: Response to "A comment on 'Osteosarcopenia: A Geriatric Giant of the XXI Century".The journal of nutrition, health & aging · 2021
    Article

Corrections and comments

• Commented on by
  Letter to the Editor: 'Giant' Claims Require Strong Evidence: A Comment on 'Osteosarcopenia: A Geriatric Giant of the XXI Century'.2021
• Commented on by
  Letter tot the Editor: Response to "A comment on 'Osteosarcopenia: A Geriatric Giant of the XXI Century".2021

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.